+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy



Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy



American Journal of Human Genetics 87(4): 560-566



Charcot-Marie-Tooth (CMT) disease comprises a genetically and clinically heterogeneous group of peripheral nerve disorders characterized by impaired distal motor and sensory function. Mutations in three genes encoding aminoacyl-tRNA synthetases (ARSs) have been implicated in CMT disease primarily associated with an axonal pathology. ARSs are ubiquitously expressed, essential enzymes responsible for charging tRNA molecules with their cognate amino acids. To further explore the role of ARSs in CMT disease, we performed a large-scale mutation screen of the 37 human ARS genes in a cohort of 355 patients with a phenotype consistent with CMT. Here we describe three variants (p.Leu133His, p.Tyr173SerfsX7, and p.Ile302Met) in the lysyl-tRNA synthetase (KARS) gene in two patients from this cohort. Functional analyses revealed that two of these mutations (p.Leu133His and p.Tyr173SerfsX7) severely affect enzyme activity. Interestingly, both functional variants were found in a single patient with CMT disease and additional neurological and non-neurological sequelae. Based on these data, KARS becomes the fourth ARS gene associated with CMT disease, indicating that this family of enzymes is specifically critical for axon function.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269085

Download citation: RISBibTeXText

PMID: 20920668

DOI: 10.1016/j.ajhg.2010.09.008


Related references

Compound heterozygosity for loss-of-function FARSB variants in a patient with classic features of recessive aminoacyl-tRNA synthetase-related disease. Human Mutation 39(6): 834-840, 2018

Thiosine-resistant mutants of Escherichia coli K-12 with growth-medium-dependent lysyl-tRNA synthetase activity.II. Evidence for an altered lysyl-tRNA synthetase. Biochimica et Biophysica Acta 259(3): 344-356, 1972

A preferential role for lysyl-tRNA4 in the synthesis of diadenosine 5',5'''-P1,P4-tetraphosphate by an arginyl-tRNA synthetase-lysyl-tRNA synthetase complex from rat liver. Biochemistry 26(6): 1586-1591, 1987

Characterization of a homogeneous arginyl- and lysyl-tRNA synthetase complex isolated from rat liver. Kinetic mechanism for lysyl-tRNA synthetase. Journal of Biological Chemistry 258(22): 13592-6, 1983

Inheritance analysis confirms compound heterozygosity of mutations in lysyl hydroxylase gene from a patient with Ehlers-Danlos syndrome type IV. Journal of Investigative Dermatology 102(4): 575, 1994

Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations. Human Mutation 35(11): 1363-1371, 2014

Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (cmtx5). American Journal of Human Genetics 81(3): 552-558, 2007

The crystal structures of T. thermophilus lysyl-tRNA synthetase complexed with E. coli tRNA(Lys) and a T. thermophilus tRNA(Lys) transcript: anticodon recognition and conformational changes upon binding of a lysyl-adenylate analogue. Embo Journal 15(22): 6321-6334, 1996

Compound heterozygosity in the GALC gene in a late onset Iranian patient with spastic paraparesis, peripheral neuropathy and leukoencephalopathy. Neurological Sciences 38(9): 1721-1722, 2017

The tandem PDZ protein Syntenin interacts with the aminoacyl tRNA synthetase complex in a lysyl-tRNA synthetase-dependent manner. Journal of Proteome Research 7(11): 4962-4973, 2008

Physical and biochemical characterization of a purified arginyl-tRNA synthetase-lysyl-tRNA-synthetase complex from rat liver. Biochemistry 21(8): 1959-1966, 1982

Compound heterozygosity of low-frequency promoter deletions and rare loss-of-function mutations in TXNL4A causes Burn-McKeown syndrome. American Journal of Human Genetics 95(6): 698-707, 2014

Lysyl-tRNA synthetase from rat liver. Partial purification and evidence that this enzyme is associated with arginyl-tRNA synthetase. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 354(9): 1027-1033, 1973

Rare recessive loss-of-function methionyl-tRNA synthetase mutations presenting as a multi-organ phenotype. Bmc Medical Genetics 14: 106, 2013

Characterization of a homogeneous arginyl- and lysyl-tRNA synthetase complex isolated from rat liver. Arginyl- and lysyl-tRNA synthetases contain carbohydrates. Biochemistry 21(20): 4891-4895, 1982